Phosphoric Acid

Phosphoric Acid

SCHEMBL2033776

O=P(O)(O)O.[H+].[K+].[K+].[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114534158-A Composite stabilizer with waste incineration fly ash heavy metal stability 天津壹鸣环境科技股份有限公司 2022-05-27 CN claimed
CN-110862372-A Synthesis of clopidogrel intermediate (S) -2- (2-thiophene ethylamino) - (2-chlorphenyl) -methyl acetate 江西川奇药业有限公司 2020-03-06 CN claimed
WO-2025094828-A1 METHOD FOR PRODUCING HETEROPOLYOXOMETALATE HAVING MODIFIED LACUNARY SITE, OR MIXTURE THEREOF 東京応化工業株式会社 2025-05-08 WO disclosed
CN-119688884-A Quality control method for synthesizing 3' -sialyllactose by enzymatic process 深圳瑞德林生物技术有限公司 2025-03-25 CN disclosed
CN-119390681-A Process for preparing COT inhibitor compounds 吉利德科学公司 2025-02-07 CN disclosed
CN-118516440-A Method for synthesizing cefaclor by catalyzing immobilized penicillin G acylase 珠海联邦制药股份有限公司 2024-08-20 CN disclosed
CN-111048697-B Organic electroluminescent blue light emitting device 三星显示有限公司 2024-08-20 CN disclosed
CN-112805267-B Carboxamide and sulfonamide derivatives as TEAD modulators 豪夫迈·罗氏有限公司 2024-03-08 CN disclosed
CN-116997529-A Method for producing dispersion of zirconium-containing metal oxide, and dispersion of zirconium-containing metal oxide 堺化学工业株式会社 2023-11-03 CN disclosed
CN-116947909-A Organic electroluminescent material and device 环球展览公司 2023-10-27 CN disclosed
CN-111606939-B Organic electroluminescent material and device 环球展览公司 2023-08-25 CN disclosed
US-20050159441-A1 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage BOEHRINGER INGELHEIM PHARMA KMBH & CO. KG (DE) 2005-07-21 US disclosed
US-20040229172-A1 Method of reusing photographic processing wastesolution, and photographic processing agent FUJIFILM CORPORATION (JP) 2004-11-18 US disclosed
US-20030066524-A1 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-10 US disclosed
US-6481435-B2 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-19 US disclosed
US-20010032643-A1 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2001-10-25 US disclosed
EP-0856770-B1 Photographic dye image-forming process EASTMAN KODAK CO (US) 2001-05-16 EP disclosed
US-6150418-A Active substance concentrate with formoterol, suitable for storage BOEHRINGER INGELHEIM PHARMA KG (US) 2000-11-21 US disclosed
EP-0856770-A1 Photographic dye image-forming process KODAK LIMITED (GB) 1998-08-05 EP disclosed
US-5741631-A REDOX AMPLIFICATION IN LOW VOLUME TANK OF DEVELOPER SOLUTION CONTAINING HYDROXYLAMINE PRESERVATIVE, REPLENISHED BY DIRECT ADDITION OF SOLIDS OR LIQUID CONCENTRATES EASTMAN KODAK COMPANY (US) 1998-04-21 US disclosed